✦ LIBER ✦

Efficacy of rituximab in the treatment of rheumatoid arthritis. Influence of serologic status, coprescription of methotrexate and prior TNF-alpha inhibitors exposure

✍ Scribed by Elisabeth Solau-Gervais; Caroline Prudhomme; Peggy Philippe; Alain Duhamel; Caroline Dupont-Créteur; Jean-Louis Legrand; Eric Houvenagel; René-Marc Flipo

Book ID: 113685110
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 210 KB
Volume: 79
Category: Article
ISSN: 1297-319X
DOI: 10.1016/j.jbspin.2011.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS28 COST-EFFICACY ANALYSIS OF TNF ALPH

PMS28 COST-EFFICACY ANALYSIS OF TNF ALPHA ANTAGONISTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS

✍ Gil-Hurlé A Dominguez; Ruiz M Costi; Sien C Campo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Efficacy and safety of rituximab with an

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register

✍ Sebastiani, Marco; Anelli, Maria Grazia; Atzeni, Fabiola; Bazzani, Chiara; Farin 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 542 KB

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (M

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND

✍ R Plisko; J Krzystek; P Rys; M Russel-Szymczyk; M Szkultecka-Debek; K Szamotulsk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

The influence of genetic variation in th

The influence of genetic variation in the HLA–DRB1 and LTA–TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept

✍ Lindsey A. Criswell; Raymond F. Lum; Kevin N. Turner; Blanche Woehl; Yuanqing Zh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 3 views

## Abstract ## Objective To examine the roles of specific genetic polymorphisms as predictors of response to treatment of early rheumatoid arthritis (RA). ## Methods Subjects included 457 patients with early RA (duration of ≤3 years) who participated in a randomized controlled trial comparing we

BL1 COST-EFFECTIVENESS, VALUE OF INFORMA

BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND

✍ EJ Soini; T Hallinen; M Taiha; V Honkanen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB